Earnings History Data for Humacyte, Inc. (HUMA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Humacyte, Inc.
Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22-03-2024 | PM | HUMA | Humacyte, Inc. | 363.55 | -0.24 | -0.25 | -0.21 | Humacyte GAAP EPS of -$0.24 in-line [3/22/2024 7:02 AM] |
3.33 | -0.27 (-7.64%) |
3.55 | -0.05 (-1.39%) |
1.96 - 5.60 | 1,106,548 | 910,000 | 33,469 | ||
| 09-11-2023 | AH | HUMA | Humacyte, Inc. | 249.28 | -0.25 | -0.25 | -0.25 | Humacyte GAAP EPS of -$0.25 in-line [11/9/2023 5:10 PM] |
2.35 | 0.14 (6.11%) |
2.28 | 0.07 (3.17%) |
1.96 - 5.60 | 695,998 | 680,000 | 7,580 | ||
| 14-08-2023 | PM | HUMA | Humacyte, Inc. | 352.35 | -0.22 | -0.22 | -0.19 | Humacyte GAAP EPS of -$0.22 [8/14/2023 11:33 AM] |
4.04 | 0.77 (23.59%) |
3.38 | 0.11 (3.36%) |
1.96 - 5.60 | 1,860,342 | 370,000 | 7,844 | ||
| 12-05-2023 | PM | 7:00 AM ET (May 12) |
HUMA | Humacyte, Inc. | 459.00 | -0.22 | -0.22 | 0.00 | Humacyte GAAP EPS of -$0.36 misses by $0.15 [5/12/2023 7:07 AM] |
3.97 | -0.27 (-6.48%) |
4.20 | -0.04 (-1.06%) |
1.96 - 6.38 | 274,302 | 430,000 | 18,940 | |
| 24-03-2023 | PM | 7:00 AM ET (Mar 24) |
HUMA | Humacyte, Inc. | 318.64 | -0.21 | -0.23 | -0.22 | Humacyte GAAP EPS of -$0.04 beats by $0.19 [3/24/2023 7:04 AM] |
2.89 | -0.20 (-6.47%) |
3.20 | 0.11 (3.56%) |
1.96 - 8.04 | 145,140 | 280,000 | 2,302 | |
| 10-11-2022 | PM | 7:00 AM ET (Nov 10) |
HUMA | Humacyte, Inc. | 332.71 | -0.25 | -0.20 | -0.50 | Humacyte GAAP EPS of -$0.25 misses by $0.04, revenue of $0.03M misses by $0.17M [11/10/2022 7:05 AM] |
3.21 | 0.07 (2.23%) |
3.13 | -0.01 (-0.32%) |
3.02 - 12.22 | 255,480 | 340,000 | 8,570 | |
| 12-08-2022 | PM | 7:00 AM ET (Aug 12) |
HUMA | Humacyte, Inc. | 354.85 | -0.19 | -0.22 | 0.00 | Humacyte GAAP EPS of $0.35, revenue of $1.3M [8/12/2022 7:07 AM] |
4.58 | 0.18 (4.09%) |
4.33 | -0.07 (-1.59%) |
3.07 - 17.45 | 1,007,386 | 580,000 | 15,500 | |
| 13-05-2022 | PM | 7:00 AM ET (May 13) |
HUMA | Humacyte, Inc. | 537.68 | -0.22 | -0.20 | 0.00 | Humacyte reports Q1 results [5/13/2022 7:23 AM] |
5.36 | 0.32 (6.35%) |
5.30 | 0.26 (5.16%) |
4.37 - 17.45 | 341,336 | 390,000 | 336 | |
| 29-03-2022 | PM | 7:30 AM ET (Mar 29) |
HUMA | Humacyte, Inc. | 664.37 | -0.22 | -0.19 | 0.00 | Humacyte GAAP EPS of $0.41 beats by $0.61, revenue of $0.18M misses by $0.07M [3/29/2022 7:10 AM] |
6.74 | 0.37 (5.81%) |
6.38 | 0.01 (0.16%) |
4.37 - 17.45 | 361,709 | 420,000 | 201 | |
|
||||||||||||||||||